{"id":2155,"company":{"country":"BM","currency":"CHF","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2014-08-06","marketCap":5.104308128356934,"name":"Altamira Therapeutics Ltd","phone":"410417297194","outstanding":8.829999923706055,"symbol":"CYTO","website":"https://aurismedical.com/","industry":"Pharmaceuticals"},"price":4.3023,"year":2023,"month":12,"day":15,"weekday":"Friday","title":"Impact of Interest Rate Fluctuations on Altamira Therapeutics Ltd stock's Performance and Valuation","date":"2023-12-15","url":"/posts/2023/12/15/CYTO","content":[{"section":"1. Stock Performance","text":"Interest rate fluctuations can affect Altamira Therapeutics Ltd stock's performance in several ways. Firstly, interest rate changes can influence the cost of borrowing for the company. If interest rates rise, it becomes more expensive for Altamira to take on debt, which can reduce their profitability and potentially have a negative impact on the stock price. Conversely, lower interest rates can decrease borrowing costs and improve profitability, potentially leading to an increase in stock price."},{"section":"2. Valuation","text":"Interest rate fluctuations can also impact the valuation of Altamira Therapeutics Ltd stock. In general, higher interest rates tend to result in higher discount rates, which can reduce the present value of the company's future cash flows. This can lead to a decrease in the stock's valuation. On the other hand, lower interest rates can result in lower discount rates, increasing the present value of future cash flows and potentially increasing the stock's valuation."},{"section":"3. Interest Rate Dynamics","text":"Interest rates are influenced by various factors, including central bank policies, inflation rates, economic growth, and market expectations. Central banks use interest rates as a tool to manage inflation and economic growth. When the economy is growing too quickly, central banks may raise interest rates to cool down inflationary pressures. Conversely, when the economy is sluggish, central banks may lower interest rates to stimulate borrowing and spending. Market expectations, based on economic indicators and forecasts, can also impact interest rates as investors anticipate future conditions."},{"section":"4. Conclusion","text":"In conclusion, interest rate fluctuations can have a significant impact on the performance and valuation of Altamira Therapeutics Ltd stock. Changes in interest rates can affect the company's borrowing costs, profitability, and the present value of future cash flows. Monitoring interest rate dynamics and understanding their potential implications is crucial for investors and analysts evaluating the stock's outlook."}],"tags":["CrossOver100","Long","Pharmaceuticals"],"news":[{"category":"company","date":1702529580,"headline":"CYTO Stock Earnings: Altamira Therapeutics Reported Results for H1 2023","id":124530129,"image":"","symbol":"CYTO","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3256593604"},{"category":"company","date":1702476063,"headline":"Altamira Therapeutics Ltd. (CYTO) Special Call Transcript","id":124490332,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"CYTO","publisher":"SeekingAlpha","summary":"Altamira Therapeutics Ltd. (NASDAQ:NASDAQ:CYTO) Special Call December 11, 2023 8:30 AM ETCompany ParticipantsThomas Meyer - Founder, Chairman and...","url":"https://seekingalpha.com/article/4657740-altamira-therapeutics-ltd-cyto-special-call-transcript"},{"category":"company","date":1702457280,"headline":"Altamira Therapeutics trading resumes","id":124504555,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3255047001"},{"category":"company","date":1702456980,"headline":"Altamira Therapeutics trading halted, volatility trading pause","id":124504556,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3255039374"},{"category":"company","date":1702363800,"headline":"Altamira Therapeutics trading halted, news pending","id":124474132,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3254152747"},{"category":"company","date":1702362780,"headline":"Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday","id":124460608,"image":"","symbol":"CYTO","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3253111961"},{"category":"company","date":1702299600,"headline":"Altamira Therapeutics Provides Investor and Business Update","id":124445193,"image":"https://media.zenfs.com/en/globenewswire.com/7088cba5de882ce449f72f383f378db2","symbol":"CYTO","publisher":"Yahoo","summary":"HAMILTON, BERMUDA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Company hosts Investor and Business Update call on December 11 at 8:30 a.m. ETPartial spin-off of Bentrio® business first step in transition to become ‘pure play’ RNA delivery companyTransition expected to complete in 2024 through partnering of further legacy assetsSpending levels and cash burn aligned with strategic repositioning and to decrease significantly in 2024 Free of financial debt following early repayment of convertible loan Expects","url":"https://finance.yahoo.com/news/altamira-therapeutics-provides-investor-business-130000363.html"},{"category":"company","date":1702297020,"headline":"Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session","id":124440107,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251695393"},{"category":"company","date":1702294560,"headline":"12 Health Care Stocks Moving In Monday's Intraday Session","id":124438974,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251636486"},{"category":"company","date":1702287000,"headline":"Altamira shares sink over 40% on corporate, stock split updates","id":124451101,"image":"","symbol":"CYTO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251462676"},{"category":"company","date":1702286820,"headline":"US Stocks Mixed; Cigna Shares Spike Higher","id":124437242,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251458910"},{"category":"company","date":1702279560,"headline":"Altamira Therapeutics to effect 20-for-1 reverse stock split","id":124451105,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251309421"},{"category":"company","date":1702279560,"headline":"Altamira says 'substantially' lowered spending levels in 2023","id":124451104,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251309417"},{"category":"company","date":1702279500,"headline":"Altamira Therapeutics to host business update conference call","id":124451107,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251308427"},{"category":"company","date":1702279500,"headline":"Altamira 'progressing' with development of OligoPhore, SemaPhore platforms","id":124451106,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251308420"},{"category":"company","date":1702279440,"headline":"Altamira Therapeutics proides update following partial Bentrio spin-off","id":124451108,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251307444"},{"category":"company","date":1701862380,"headline":"12 Health Care Stocks Moving In Wednesday's Intraday Session","id":124338947,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244316922"},{"category":"company","date":1701846540,"headline":"12 Health Care Stocks Moving In Wednesday's Pre-Market Session","id":124332434,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3243963185"},{"category":"company","date":1701833760,"headline":"12 Health Care Stocks Moving In Wednesday's After-Market Session","id":124344289,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244684972"},{"category":"company","date":1701798840,"headline":"Altamira Therapeutics to Host Investor \u0026 Business Update Call on  December 11th","id":124316710,"image":"https://media.zenfs.com/en/globenewswire.com/7088cba5de882ce449f72f383f378db2","symbol":"CYTO","publisher":"Yahoo","summary":"HAMILTON, BERMUDA , Dec. 05, 2023 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA--December 5, 2023--Altamira Therapeutics Ltd. (\"Altamira\" or the \"Company\") (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, announced today that it will host an Investor and Business Update Call on Monday, December 11, 2023, 8:30 a.m. ET. The presentation will be available via teleconference or webcast with audio and presenter-controlled slides. Webcast Access: Date:","url":"https://finance.yahoo.com/news/altamira-therapeutics-host-investor-business-175400648.html"}]}